Empire Life Investments Inc. - STEMLINE THERAPEUTICS INC ownership

STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 100 filers reported holding STEMLINE THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 2.22 and the average weighting 0.2%.

Quarter-by-quarter ownership
Empire Life Investments Inc. ownership history of STEMLINE THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$4,556,000
-25.1%
941,249
+64.5%
0.42%
-9.9%
Q4 2019$6,083,000
+13.6%
572,223
+11.3%
0.46%
+3.3%
Q3 2019$5,354,000
+3.8%
514,269
+52.8%
0.45%
+7.4%
Q2 2019$5,157,000
+7.5%
336,624
-9.8%
0.42%
+3.7%
Q1 2019$4,795,000
+35.0%
373,186
-0.2%
0.40%
+26.0%
Q4 2018$3,552,000
+115.9%
373,863
+277.2%
0.32%
+155.2%
Q3 2018$1,645,000
+203.5%
99,121
+193.6%
0.12%
+220.5%
Q2 2018$542,000
+5.4%
33,764
+0.4%
0.04%
+8.3%
Q1 2018$514,000
-1.9%
33,6130.0%0.04%
-10.0%
Q4 2017$524,000
+40.5%
33,6130.0%0.04%
+33.3%
Q3 2017$373,00033,6130.03%
Other shareholders

There were no reported owners of STEMLINE THERAPEUTICS INC in Q4 2019.

NameSharesValueWeighting ↓
View complete list of STEMLINE THERAPEUTICS INC shareholders